Tag: Advanced lung cancer options

Home / Advanced lung cancer options

Categories

Osimertinib with chemotherapy is approved by the USFDA for EGFR-mutated non-small cell lung cancer

The Food and Drug Administration approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) in combination with platinum-based chemotherapy for patients with locally advanced or metastatic non-s...
advanced-lung-cancer-options

Scan the code